BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30728354)

  • 1. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.
    Czechowicz A; Palchaudhuri R; Scheck A; Hu Y; Hoggatt J; Saez B; Pang WW; Mansour MK; Tate TA; Chan YY; Walck E; Wernig G; Shizuru JA; Winau F; Scadden DT; Rossi DJ
    Nat Commun; 2019 Feb; 10(1):617. PubMed ID: 30728354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation.
    Li Z; Czechowicz A; Scheck A; Rossi DJ; Murphy PM
    Nat Commun; 2019 Feb; 10(1):616. PubMed ID: 30728353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model.
    Uchida N; Stasula U; Demirci S; Germino-Watnick P; Hinds M; Le A; Chu R; Berg A; Liu X; Su L; Wu X; Krouse AE; Linde NS; Bonifacino A; Hong SG; Dunbar CE; Lanieri L; Bhat A; Palchaudhuri R; Bennet B; Hoban M; Bertelsen K; Olson LM; Donahue RE; Tisdale JF
    Nat Commun; 2023 Oct; 14(1):6291. PubMed ID: 37828021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
    Russkamp NF; Myburgh R; Kiefer JD; Neri D; Manz MG
    Exp Hematol; 2021 Mar; 95():31-45. PubMed ID: 33484750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice.
    Gao C; Schroeder JA; Xue F; Jing W; Cai Y; Scheck A; Subramaniam S; Rao S; Weiler H; Czechowicz A; Shi Q
    Blood Adv; 2019 Sep; 3(18):2700-2711. PubMed ID: 31515232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental drug delivery for treatment of congenital hematopoietic disorders.
    Derderian SC; Moradi PW; MacKenzie TC
    J Pediatr Surg; 2015 Sep; 50(9):1517-20. PubMed ID: 25783323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.
    Yeung J; Liao A; Shaw M; Silva S; Vetharoy W; Rico DL; Kirby I; Zammarchi F; Havenith K; de Haan L; van Berkel PH; Sebire N; Ogunbiyi OK; Booth C; Gaspar HB; Thrasher AJ; Chester KA; Amrolia PJ
    Mol Ther; 2024 Jun; 32(6):1672-1686. PubMed ID: 38549377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.
    Derderian SC; Togarrati PP; King C; Moradi PW; Reynaud D; Czechowicz A; Weissman IL; MacKenzie TC
    Blood; 2014 Aug; 124(6):973-80. PubMed ID: 24879814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice.
    Kwon HS; Logan AC; Chhabra A; Pang WW; Czechowicz A; Tate K; Le A; Poyser J; Hollis R; Kelly BV; Kohn DB; Weissman IL; Prohaska SS; Shizuru JA
    Blood; 2019 May; 133(19):2104-2108. PubMed ID: 30617195
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.
    Xue X; Pech NK; Shelley WC; Srour EF; Yoder MC; Dinauer MC
    Blood; 2010 Dec; 116(24):5419-22. PubMed ID: 20813896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin.
    Palchaudhuri R; Saez B; Hoggatt J; Schajnovitz A; Sykes DB; Tate TA; Czechowicz A; Kfoury Y; Ruchika F; Rossi DJ; Verdine GL; Mansour MK; Scadden DT
    Nat Biotechnol; 2016 Jul; 34(7):738-45. PubMed ID: 27272386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.
    Pang WW; Czechowicz A; Logan AC; Bhardwaj R; Poyser J; Park CY; Weissman IL; Shizuru JA
    Blood; 2019 May; 133(19):2069-2078. PubMed ID: 30745302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.
    Czechowicz A; Kraft D; Weissman IL; Bhattacharya D
    Science; 2007 Nov; 318(5854):1296-9. PubMed ID: 18033883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
    Ishida T; Suzuki S; Lai CY; Yamazaki S; Kakuta S; Iwakura Y; Nojima M; Takeuchi Y; Higashihara M; Nakauchi H; Otsu M
    Stem Cells; 2017 Apr; 35(4):989-1002. PubMed ID: 27753160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioning.
    Ibrahim AA; Yahata T; Muguruma Y; Miyata T; Ando K
    Biochem Biophys Res Commun; 2019 Aug; 516(2):500-505. PubMed ID: 31230745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo hematopoietic stem cell modification by mRNA delivery.
    Breda L; Papp TE; Triebwasser MP; Yadegari A; Fedorky MT; Tanaka N; Abdulmalik O; Pavani G; Wang Y; Grupp SA; Chou ST; Ni H; Mui BL; Tam YK; Weissman D; Rivella S; Parhiz H
    Science; 2023 Jul; 381(6656):436-443. PubMed ID: 37499029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tussilago farfara L. Polysaccharides on the Content of Hematopoietic Stem Cells (CD117
    Safonova EA; Lopatina KA; Dyagel AR; Razina TG; Krylova SG; Gur'ev AM; Belousov MV; Zueva EP
    Bull Exp Biol Med; 2020 Nov; 170(1):171-174. PubMed ID: 33231808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.
    Bankova AK; Pang WW; Velasco BJ; Long-Boyle JR; Shizuru JA
    Blood Adv; 2021 Oct; 5(19):3900-3912. PubMed ID: 34448832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: effects of a retroviral-mediated gene transfer protocol and implications for gene therapy.
    Goebel WS; Yoder MC; Pech NK; Dinauer MC
    Exp Hematol; 2002 Nov; 30(11):1324-32. PubMed ID: 12423686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.